secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edwards Lifesciences Corp (EW)
CIK:        0001099800
Form:       8-K
Filed at:   2023-05-15T23:59:59+00:00
Accession:  0001193125-23-144564
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Edwards Lifesciences raises CEO Zovighian's base salary to $1.05M; shareholders approve officer exculpation
--------------------------------------------------------------------------------

- Board increased Bernard J. Zovighian's base salary to $1,050,000 and annual incentive target to $1,470,000, effective May 11, 2023.
- Stockholders approved amendment to certificate of incorporation to provide officer exculpation under Delaware law; filed May 12, 2023.
- All nine director nominees elected; say-on-pay advisory vote approved with 438.1M for; one-year frequency chosen for future votes.
- Shareholder proposal for independent board chairman policy rejected with 371M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1099800/000119312523144564/0001193125-23-144564-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1099800/000119312523144564/d427364d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-144564

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer